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Rheumatic fever (RF) and rheumatic heart disease (RHD) are the most-common cardiovascular
disease in young people aged <25 years, globally. They are important contributors to cardio-
vascular morbidity and mortality in Bangladesh. Classical risk factors, i.e. poverty, over-
crowding, ignorance, and insufﬁcient health care services were responsible for the high
incidence and prevalence of these diseasesover the last century. In concert with the progresses
in socioeconomic indicators, advances in health sectors, improved public awareness, and
antibiotic prophylaxis, acute RF came into control. However, chronic RHD continues to be
prevalent, and the actual disease burden may be much higher. RHD predominantly affects the
young adults, seriously incapacitates them, follows a protracted course, gets complicated
because of delayed diagnosis and is sometimes maltreated. The treatment is often palliative
and expensive. Large-scale epidemiological and clinical researches are needed to formulate
evidence-based national policy to tackle this important public health issue in future.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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Rheumatic fever (RF) and rheumatic heart diseases (RHDs) are
important medical and public health issues, because they are
common and are important causes of cardiovascular morbidi-
ty and mortality especially in developing world. Over 15
million people around the world suffer from RHD, which kills
hundreds of thousands of people a year, and is the most
common acquired heart disease in children and young people
in developing countries.1 Acute RF – the precursor to RHD –
results from an abnormal autoimmune response to group A* Corresponding author.
E-mail address: drmonwarbd@yahoo.com (A.K.M. Monwarul Islam
http://dx.doi.org/10.1016/j.ihj.2015.07.039
0019-4832/# 2015 Cardiological Society of India. Published by Elseviebeta-hemolytic streptococcus (GABHS) infection in a geneti-
cally susceptible host. It affects the heart, joints, brain, and
subcutaneous tissue; however, when affected, heart valves
bear the brunt of RF. Although penicillin is effective in the
prevention of the disease, treatment of advanced stages uses
up a vast amount of resources, which makes disease
management especially challenging in emerging nations.2
Bangladesh has been experiencing epidemiological transi-
tion from communicable disease to non-communicable
disease. The overall mortality has decreased signiﬁcantly over
the couple of decades. But deaths due to chronic diseases,
specially the 'fatal four', i.e. cardiovascular disease (CVD),).
r B.V. All rights reserved.
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ing in an alarming rate.3 RF and RHD are contributors to one of
the four, i.e. CVD. In the past few decades, incidence and
prevalence of acute RF have decreased much, but chronic RHD
continues to be rampant in this population.
2. Rationality of the review
Data related to RF and RHD in Bangladesh are often
insufﬁcient, suffer from statistical ﬂaws and are not readily
available. Many articles were published in local, non-indexed
journals which are not available online and difﬁcult to procure.
Recognizing these limitations, the present review has been
planned to compile the available data on this important public
health issue. This review will hopefully stimulate future
research and act as a valuable source of information.
3. Methods
Data have been collected from the articles available from
MEDLINE and BanglaJOL supported by the International
Network for the Availability of Scientiﬁc Publications (INASP)
up to the year 2014. Besides this, local journals which are not
available online but recognized by the Bangladesh Medical and
Dental Council have also been considered.
4. Epidemiology of RF and RHD in Bangladesh
RHD ranks among the leading causes of non-communicable
diseases in low-income and middle-income countries and
accounts for up to 250,000 premature deaths every year
worldwide.4 In a recent systematic review and meta-analysis
including 37 populations in endemic regions around the world,
the pooled prevalence of RHD among children and adolescents
(≥5 years to <18 years) detected by cardiac auscultation was 2.9
per 1000 people and by echocardiography it was 12.9 per 1000
people, with substantial heterogeneity between individual
reports for both screening modalities.5 Historically, RF and
RHD were generally believed to be diseases of temperate
climates and rarities in tropical countries. In 1930, RF was
reported to be non-existing in this part of the world.6 In the
early 1950s, non-existence of RF in tropical climate was
claimed by Paul White, who advised the rheumatic family to
take permanent residence in the tropics to avoid RF.7 Boyd
states 'in the tropics, where hemolytic streptococci are rarely
found in the throat, scarlet fever is uncommon and RF is very
uncommon'.8 In 1957, Ibrahim quoted that, his medical
teachers Drs. D.N. De, J.C. Banerjee, and A.K.M. Abdul Wahed,
Professors of Medicine of Calcutta and Dacca Medical Colleges,
always state that 'RF is as common in Bengal as in other parts
of the world, where its incidence is frequent'.9 In the course of
5 years from January 1949 to December 1953, out of 19,011
patients admitted in Medical Wards of Dacca Medical College,
East Pakistan, acute RF and RHD constituted 606 cases (acute
RF 85, RHD 521).9 The exact incidence and prevalence of RF and
RHD in Bangladesh are not known. Only a limited number of
small-scale hospital, school, and community surveys areavailable. Another limitation is that acute RF, recurrence of RF,
and chronic RHD have been described together arbitrarily, and
their separate values are often obscure. In the 2nd half of the
last century, RF and RHD constituted a signiﬁcant proportion
of admissions in general hospitals, and a lion's share of
cardiovascular admissions.10–12 However, the situation gradu-
ally improved. During July 1995 to June 1997, out of 4410
cardiac patients admitted in 13 regional and tertiary care
hospitals across the country, 13% were due to RF and RHD.13
Probably the community prevalence of RF and RHD was ﬁrst
reported in 1976, which was 7.5/1000 in general population, i.e.
the second-most prevalent cardiac disease (hypertension 11.0/
1000), and even more prevalent than IHD (3.3/1000).14 In 1984,
almost similar prevalence was found in a rural population.15
Subsequent surveys involving rural,16 mixed,17 and urban18
population found lower prevalence of RF and RHD. High
prevalence of RF (43.9/1000) and RHD (5.05/1000) was reported
in a school survey involving 4349 children aged 4–17 years in
Dhaka City in 1984–1985.19 Subsequent school surveys
revealed lower prevalence.20–23 Most of these studies suffer
from methodological ﬂaws and lack uniformity in criteria used
for diagnosis. Over the past 3 decades, like many other parts
of the world, the incidence and prevalence of acute RF in
Bangladesh decreased; however, RHD continues to be an
important public health problem here. Current prevalence of
RF and RHD is not exactly known, however, may be <1/1000
in general population. Recently, conventional and portable
echocardiography is being used increasingly in studies con-
cerning RF and RHD, as a result, more and more subclinical cases
of RHD are being diagnosed. So, the prevalence of RF and RHD
estimated so far may not be accurate, and the true prevalence of
RHD may be much higher in Bangladesh as well (Table 1).
Data on prevalence of streptococcal sore throat in
Bangladesh are sparse. In a study24 carried out in 1982–1984,
out of 7542 throat swab specimens from sore throat patients,
beta hemolytic streptococci (BHS) were found in 20.22%. Anti-
streptolysin O (ASO) titer was determined in 5678 cases of this
study, 17.11% showed raised titer, i.e. >200 Todd units.
Prevalence of BHS found in subsequent studies ranged from
11 to 33% in different populations25–30; 6–21.5% of the BHS
belonged to group A.26–29 Considering these ﬁgures, the
prevalence of BHS in Bangladeshi children and young adults
may be 20% on an average, of which 15% may be of group A.
Highest incidence of streptococcal sore throat was found
during August to December (Table 2).31
5. Emerging issues in epidemiology of RF and
RHD
Traditionally, RHD was diagnosed by auscultation for a heart
murmur with a stethoscope in those with a history of acute RF.
Echocardiography, introduced later on, has proven to be
more sensitive and speciﬁc than auscultation, and introduc-
tion of echocardiography in studies on RF and RHD leads to
detection and inclusion of previously unrecognized cases of
subclinical carditis, which exists at rates several times
higher than that diagnosed by examination alone.32,33 RHD
detected on echocardiography without an associated clinically
pathological cardiac murmur is referred to as 'subclinical
Table 1 – Prevalence of RF and RHD in Bangladesh.
Reference Year Place Age
(years)
RF & RHD
prevalence
No.
screened
Echo Type of study
Malik14 1976 Dhaka City
and a village
Different
ages
7.5/1000, combined
RF and RHD
7062 No Community project
Hussain15 1984 Rural Different
ages
7.8/1000 No Community project
Ahmed
et al.16
1991 Rural 5–15 RF 1.2/1000; RHD
1.3/1000
5923 Yes, in selected
cases
Community project
Haque
et al.17
1992 Dhaka City
and rural
areas
5–15 3.6/1000, combined
RF and RHD
Urban 9875,
rural 5923
Yes, in selected
cases
School and house to
house survey
Hossain
et al.18
2005–2006 Dhaka City 5–22 RF 0.5/1000; RHD
0.4/1000
10,017 Yes, in selected
cases
Community project
Banoo
et al.19
1984–1985 Dhaka City 4–17 RF 43.9/1000; RHD
5.05/1000
4349 No School survey
Janan20 1978–1979 Dhaka City 5–25 RF 8.5/1000 3428 No School survey; studied
RF cases only
Mahmud
et al.21
1989 Dhaka City 5–18 RF 0.85/1000; RHD
2.8/1000
5011 Yes, in selected
cases
School survey
Begum
et al.22
1990–1991 Dhaka City 5–18 RF 2.37/1000; RHD
0.189/1000
10,538 Yes, in selected
cases
School survey
Majumder
et al.23
2004 Rural 5–16 RF 4.22/1000; RHD
0/1000
No School survey
RF: rheumatic fever; RHD: rheumatic heart disease.
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possibility that people with previously undiagnosed RHD,
including those without a known history of acute RF, can be
diagnosed and secondary prophylaxis started at an earlier
stage of the illness than previously possible, thus potentially
reducing morbidity and mortality.34 However, despite greatlyTable 2 – Prevalence of streptococcal sore throat in Bangladesh
Reference Year Place Age (years) 
sc
Chowdhury
and Rahman24
1982–1984 Dhaka City Different ages 75
Hussain and
Rahman25
1987 Dhaka City Different ages 15
Rouf et al.26 1992 Patients
attending
NCCRF&HD
5–15 22
Rouf et al.27 1992 Dhaka City 5–15; school
children
32
Faruq et al.28 1993 Dhaka City School children 60
Ahmed et al.29 1999 Narayangonj School children 68
21
th
Haque et al.30 2001 Dhaka <10 20
NCCRF&HD: National Centre for Control of Rheumatic Fever and Heart D
anti-streptolysin O.improved sensitivity, speciﬁcity of portable echocardiography
is still a concern, and the natural history of RHD in children
with subclinical abnormalities detected by echocardiographic
screening remains largely unknown, and long-term follow-up
studies are needed.35 Recently in 2012, World Heart Federation
(WHF) proposed new criteria for echocardiographic diagnosis.
No.
reened
Culture
positive for
BHS (%)
Group A BHS
(% of BHS)
ASO titer
42 20.22% 17.11% > 200
Todd units
10 19.3%
24 18.3% 20.8%
9 33.0% 7.6% 100–300 IU/ml in 88%
1 22% 18.9% 39% of BHS positives
has raised ASO titer
90 total;
75 sore
roat
19.68% of sore
throat cases
21.5%
0 11%
iseases, Dhaka, Bangladesh; BHS: beta hemolytic streptococcus; ASO:
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standardization of RHD diagnosis, increasing the speciﬁcity.
6. Risk factors of RF and RHD in Bangladesh
Like other developing countries, Bangladesh has most of the
recognized risk factors making her a fertile soil for RF and RHD.
Its geographical condition, climate, socio-economic condition,
and prevalence of streptococcal infection are as marked as any
other country where RF is known to be prevalent.9
6.1. Poverty
Bangladesh is a developing country with a population of about
153 million. At the time of independence in 1971, the country
was desperately poor, and densely populated, with an agrarian
economy subject to frequent natural disasters.36 In 1974 World
Atlas ranking of per capita income, Bangladesh came the 2nd
lowest, slightly ahead of Rwanda.37 Henry Kissinger labeled
Bangladesh as a country without hope.38 Poverty and income
inequality remain a persistent challenge in Bangladesh. The
gross national income per capita is only 2030 (PPP int. $) whereas
the global average is 12,018; 43.3% of the population in
Bangladesh lives on <$1 (PPP int. $) a day (MDG 1) – which is
almost double the global average of 22.7%.39 According to the
Nutrition, Health and Demographic Survey of Bangladesh-2011
(NHDSBD-2011),40 14.4% household sometimes and 11.2%
household often face food shortage at national level. Among
the households experiencing at least some sort of food shortage,
81% households sometimes and 14% households often remain
anxious about the next meal. Such a poor background can
explain the prevalence of RF and RHD in Bangladesh.
6.2. Overcrowding
Bangladesh has one of the highest population densities in the
world, with an average of 964 inhabitants per square
kilometer; only Singapore and small city-states such as
Bahrain or the Vatican have higher ﬁgures.41 Due to ﬁnancial
stringency, people tend to live in a crowded environment. As a
result of economic transition, rural people migrate to the
cities, often residing in the slums with minimum facilities.
Slums now make up about a third of the city corporations, and
in 20 years, slums will be half of the city corporations.42 On an
average, each household consists of 4.35 to 5.0 members40,43–
45; 70% of the households in Bangladesh have 3 to 5 members.40
One of the most practical indicators of the extent of crowding
in households is the number of rooms used for sleeping.
Crowding in one sleeping room facilitates the risks of
infection. Forty-two percent households use only 1 room,
and 35.7% household use 2 rooms for sleeping nationally,40
with per capita availability of bed room space approximately
5 m2 (55 square feet).45 Such an overcrowding makes them
prone to streptococcal infection. A retrospective study to see
the status of housing and living environment of the patients of
RF attending the National Centre for Control of Rheumatic
Fever & Heart Diseases (NCCRF&HD), Dhaka, from 1993 to 1996
showed that family comprising of more members, type of
residing house especially Kutcha house (houses made frommud, thatch, or other low-quality materials), and house
consisting of less living rooms increases the incidence of RF.
Fifty four percent patients out of 477 came from a family
comprising of ≥7 members and 41% from a family comprising
of 4–6 members; 50.1%, 32.9%, and 17% resides in Kutcha,
Pucca (houses made with high quality materials throughout,
including the ﬂoor, roof, and exterior walls) and semi-Pucca
(houses that have ﬁxed walls made up of Pucca material but
roof is made up of the material other than those used for Pucca
house) house, respectively; 67% and 27.9% of the patients came
from the house consisting of 1–2 and 3–4 living rooms,
respectively.46
6.3. Malnutrition
Malnutrition, especially protein energy malnutrition is an
important public health problem in Bangladesh. Presence of
malnutrition weakens the immune system of the body,
making them easy prey to streptococcal infection. Nearly half
of children in Bangladesh have chronic malnutrition. Preva-
lence of stunting (low height-for-age) in children <5 years was
42% in 2010.47 In the NHDSBD-2011, at national level in
children <5 years the prevalence of stunting (low height-for-
age) is about 40.2% in both girls and boys, severe stunting 17%;
wasting (low weight-for-height) 25.3% in girls and 22.3% in
boys, severe wasting 6.5% in girls and 7.2% in boys; and
underweight (low weight for age) about 45% in both girls and
boys, severe underweight is 17.3% in girls and 15.3% in boys.40
According to the Household Income and Expenditure Survey
2010 (HIES-2010), per capita per day food intake was 1000 g,
protein intake 66.26 g, and total calorie intake 2318.3 kcal.44 In
a case-control study48 carried out in NCCRF&HD, higher risk of
RF was observed for low height for age, low weight for age, low
upper arm circumference for age, and low consumption of
eggs, milk, chicken, pulses, fruits, and roti (home-made bread).
Reduced risk was observed for soybean oil consumption. Also,
low serum albumin concentrations and body iron stores were
found to increase the risk of acquiring RF in Bangladeshi
children.49
6.4. Inadequate health care facilities
Health care facilities in Bangladesh are often inadequate. In
2011, the percentage of gross domestic product (GDP) alloca-
tion for health was 3.8%, which is much lower than the values
of low income (5.2%) and global (9.1%) averages. In terms of per
capita total expenditure on health at average exchange rate,
the country spent USD 27 in 2011; again under half the regional
(World Health Organization (WHO) South-East Asia Region)
average of USD 69, and far below the global average of USD
1007.39 Bangladesh is one of the health workforce crisis
countries in the world. On a per capita basis, there are fewer
practicing physicians in the Bangladesh, i.e. 3.6/10,000
population; the regional (WHO South-East Asia Region) and
global averages are 5.6 and 14.1, respectively. The availability
of nursing and midwifery personnel is 2.2/10,000 population;
the regional (WHO South-East Asia Region) average is 15.3, and
global average is 29.2. Also, for 10,000 population, only 6
hospital beds are available.39 Often the rural people and people
residing in slums in cities suffer from scarcity of quality
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ignorance, and difﬁcult commutation. A recent study50 in a
remote rural area in Bangladesh showed that only 47% of the
765 randomly chosen patients sought treatment for their illness
from a healthcare provider; out of them, 65% consulted non-
graduate village doctors and consultation with graduate
(MBBS) doctors was low at 14%. Of the 407 household members
who did not seek care for their illness, 40% did not have enough
money to consult a healthcare provider.
6.5. Ignorance
Besides poverty and scarcity of resources, ignorance appears
to play important role in the prevalence of acute RF and RHD in
Bangladesh. Literacy rate in Bangladesh is low, 38.22% people
have got no education, only 55.08% of those aged ≥5 years can
write a letter for communication.51 These people often cannot
realize the importance of timely proper treatment of ailment,
existing healthcare facilities, and their rights, and they easily
become the victim of delayed treatment or maltreatment.
According to the HIES-2010,44 the main reason of non-
treatment for ailments is the perceived non-serious nature
of the disease (56.54%) followed by high cost of treatment
(15.57%), and nonsupport from the family (3.89%). Also, 40.21%
received treatment from pharmacy/dispensary/compounder
followed by private doctor (24.46%) and government doctors in
private practice (14.34%). In a study involving rural population,
only half (49.8%) of the sore throat cases sought treatment;
38.8% from medicine shops, 27.2% from qualiﬁed doctors, 13.6%
from hospitals, and 13.6% from homeopathic practitioners.52
The situation was equally gloomy in a more recent study.50Such
an attitude favors streptococcal infection getting untreated,
resulting in complications, i.e. RF and consequent RHD.
6.6. Social stigmata
Social stigmata often hinder to timely proper treatment,
especially of chronic RHD. Younger people, especially the
females of lower socioeconomic class are mainly affected by
chronic RHD. Despite improvement in women empowerment
as a whole, females are often neglected in the society; their
illness is relatively overlooked; medical attention is often
delayed or denied, meanwhile, they are maltreated, and the
disease becomes complicated. Sometimes, in case of RF or
established RHD, treatment or prophylaxis is not adopted,
continued, or is kept conﬁdential during and after marriage.
The worst thing is that they may ultimately be divorced.
6.7. Genetic factors
The likelihood of genetic susceptibility to acute RF is high,
given the increased occurrence of acute RF among families and
monozygotic twins. A recent systematic review and meta-
analysis of twin studies of concordance of acute RF in order to
derive quantitative estimates of the size of the genetic effect,
the pooled probandwise concordance risk for acute RF was 44%
in monozygotic twins and 12% in dizygotic twins, and the
association between zygosity and concordance was strong
(odds ratio (OR) 6.39; 95% conﬁdence interval, 3.39–12.06;
p < 0.001); the estimated heritability across all the studies was60%.53 The HLA-D8/17 and HLA-DR7 types are the most
represented.54 The variability in reported HLA alleles associ-
ated with acute RF and RHD could be due to genetic differences
in the populations studied or differences in local streptococcal
strains.54 However, the contribution of genetics and ethnicity
to the high prevalence of RF and RHD in Bangladeshi
population has not been studied.
6.8. Lack of compliance to secondary prophylaxis
Lack of compliance to secondary prophylaxis of RF and RHD is
especially important, because it leads to recurrent acute or
clinically silent RF and consequent more chance of develop-
ment or worsening of chronic RHD. In a study involving 106
patients of acute RF at Dhaka Shishu Hospital in 1987–1989,
only 1% used secondary prophylaxis regularly and 9% used
irregularly.55 Another study during 1990–1992 showed that, out
of 74 children who received ﬁrst dose of injectable penicillin for
secondary prophylaxis in a hospital, 22.9% never came back for
the second dose; 10.8% attended the hospital irregularly because
of ignorance (6.75%) and ﬁnancial stringency (4.05%).56 Interest-
ingly, in a hospital-based study, secondary prophylaxis was
discontinued prematurely by the physicians in 82.92% cases.57
Recurrences of RF was observed in a study involving 56 cases
of RF and RHD, who were on injectable penicillin; after 4 years of
prophylaxis, there was 12.5% recurrences, which was more
common in case of 4-weekly regimen.58
The pattern of risk factors related to RF and RHD in
Bangladesh has remained more or less unchanged over
decades.9,59,60 A hospital-based case-control study59 carried
out more than a decade ago found that RF was signiﬁcantly
associated with low income, poor living conditions (substan-
dard house), and poor nutritional status (low height for age). RF
and RHD were found to share almost similar risk factors in a
more recent study.60 Women, urban resident, dwellers in
brick-built house, having >2 siblings, offspring of working
mothers, illiterate mother, and those who did not brush teeth
after taking meals were more likely to develop RF and RHD.
7. Trends of RF and RHD in Bangladesh
Until recent past, RF was a common disease in Bangladesh,
constituting considerable portion of hospital admissions.
Classically, the disease affects the children and young adults,
most commonly between 5 and 15 years of age; in a hospital-
based study in Bangladesh, 90% of the acute RF patients were
aged 4–15 years and 3% <5 years.61 The age reference range for
occurrence of RF in Bangladesh was suggested to be 5–22 years
in a study.62 Subsequently, like some other parts of the world,
there was a deﬁnite trend toward steady decline in incidence
and prevalence of RF in the country.63 On the other hand,
despite lower incidence of clinically apparent acute RF,
continuing high incidence and prevalence of chronic RHD is
a reality. In this population, RHD has a malignant course, and
the natural history is accelerated as evidenced by the lower
mean age of the patients, younger age for the initial attack of
RF, and short interval between the initial attack of RF and onset
of symptomatic valvular disease.64 In a study of 776 patients of
mitral stenosis (MS), 38% belonged to juvenile age group, i.e.
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high degree of incapacity, low incidence of atrial ﬁbrillation
(AF) and embolism, rapid development of pulmonary hyper-
tension, and high incidence (80%) of active Aschoff's bodies in
the sub-endocardium were the remarkable features.65 Some-
times, the disease is diagnosed for the ﬁrst time during
pregnancy or childbirth, endangering the life of both mother
and child. In a study involving 25 pregnant women with MS,
there was high maternal morbidity, but rare mortality, and
miscarriage rate was 32%.66
The RF patients were managed by the cardiology and
medicine departments of various secondary and tertiary
health care institutions. ASO titer and throat swab culture
were important diagnostic tools. Echocardiography was
initially not available; for the ﬁrst time, it was introduced in
1980 in Bangladesh (Islam MN, Professor of Cardiology and
Former Director, NICVD; Zafar MA, Professor of Cardiology and
Former Director, NICVD, personal communication, 15 Oct
2014). Oral and imported injectable penicillins were used for
prophylaxis. National Institute of Cardiovascular Diseases
(NICVD), the state-of-the-art institution for CVDs, was estab-
lished in 1978, and was formally opened on the 3rd April 1981.
Soon after its inception, management of heart disease as a
whole got momentum, and became more organized. After a
decade, with a view to control and prevention of RF and RHD,
Government of Bangladesh started a 5-year pilot project in
1988 in collaboration with the Government of Japan through
technical cooperation program of Japan International Cooper-
ation Agency (JICA); NCCRF&HD was established on 1st
November 1988. RF and RHD cases were diagnosed and
managed more efﬁciently, and besides curative services,
preventive and promotive services were delivered. A large
number of research works were conducted, and manpower
was trained abroad. RF became virtually a subject of social
movement, leading to improved public awareness.
Despite much progress, considerable fallacies exist in
relation to diagnosis, management, and prophylaxis of RF
and RHD in Bangladesh. RF is often diagnosed, better to say,
misdiagnosed, on the basis of raised ASO titer which is an
easily available and commonly asked test, sometimes with no,
or only mild joint pain. Mechanical musculoskeletal pain, and
mild febrile illness or vague ailments are sometimes diag-
nosed and treated as and prophylaxis given for RF. In a
hospital-based study, out of 82 children receiving long-term
penicillin therapy, only 7.31% had documented evidence of RF
by Jones' criteria.57 Streptococcal infection is presumably a
common phenomenon in Bangladesh, especially in low
socioeconomic class, and raised ASO titer merely supports
its occurrence. About 60–80% of the healthy population may
show an elevated ASO titer (>300 IU/ml in children) in
developing countries like ours,67 single raised ASO titer may
not equate to acute RF, so paired sera collected at an interval of
4–8 weeks with 2-fold increase or decrease has been suggested
to give a more meaningful interpretation.68 Similarly, a
negative ASO titer does not exclude the diagnosis of acute
RF.69 A study to ﬁnd out the reference value of streptococcal
antibodies among apparently healthy primary school children
in rural Bangladesh found the geometric mean titer to be
241 IU/ml and 222 IU/ml, and the upper limit of normal values
(80th percentile) to be 390 IU/ml and 340 IU/ml for ASO andanti-deoxyribonuclease B, respectively.70 On the other hand,
use of Jones' criteria appears to be neglected even by the
physicians. However, once 'diagnosed', these patients are kept
on oral or intramuscular penicillin prophylaxis for years
together. A portion of these cases are presumably of post
streptococcal reactive arthritis, other inﬂammatory arthropa-
thies, or even ﬁbromyalgia or hypovitaminosis D. Hypovita-
minosis D affects almost 50% of the population worldwide.
Patients with vitamin D deﬁciency may present with muscu-
loskeletal pain. High prevalence of hypovitaminosis D has
been reported in Bangladeshi population.71–73 Some patients
presenting with musculoskeletal symptoms and provisionally
diagnosed as RF may actually be cases of hypovitaminosis D.
Though acute cases of acute RF are uncommon at present
in Bangladesh, clinically silent subclinical cases of carditis
continue to occur, which is evidenced by the high prevalence
of chronic RHD. Actually, prevalence of RHD in a population
provides a better indicator of the real frequency of RF.74
Chronic RHD itself has a relatively long natural history, and
clinical manifestations may occur only in moderate or severe
disease, leading to delay in diagnosis. In a clinical study on the
pattern of mitral valvular disease conducted in a peripheral
tertiary hospital in Bangladesh,75 signiﬁcant delay was found
in 56% patients; illiteracy and ignorance was found to be the
cause in 28% cases, poverty in 24%, and misdiagnosis in 14%;
12% patients adopted indigenous treatment. The common
clinical features of mitral valvular disease, particularly,
breathlessness, is taken as for bronchial asthma especially
by the non-graduate medical practitioners. Cough and
hemoptysis accompanied by pulmonary hypertension associ-
ated with severe mitral stenosis, is sometimes misdiagnosed
as pulmonary tuberculosis even by the less experienced
doctors.75 People with established chronic RHD, especially
mitral valvular disease, suffer from chronic morbidity
compromising their productivity and leading to loss of job.
In a study involving 1427 patients, 61% were severely
incapacitated by the disease,64 while 63% of 245 isolated MS
patients aged <20 years were in New York Heart Association
(NYHA) class III or IV in a separate series.76 One well-
recognized complication of rheumatic mitral valvular disease
is AF, which was present in 2% in juvenile MS in a study.76 The
AF in RHD, is usually refractory to cardioversion. Antic-
oagulants are often under-prescribed, presumably due to
undue fear of bleeding on the part of physician, or inadequate
access to proper monitoring on the part of the patients,
specially those residing in remote and rural areas. These
patients sometimes develop stroke, further worsening their
sufferings and compromising productivity. In a study involv-
ing 245 isolated MS patients aged <20 years, 3% patients
presented with systemic thromboembolism.65
8. Changing scenario in Bangladesh
Initial success in control of RF and chronic RHD is probably the
result of intense, speciﬁc primary and secondary prevention
measures adopted nationally in eighties and nineties in the
last century. On the other hand, the present achievement in
this arena appears mostly passive, i.e. the by-product of the
country's socioeconomic transition in general, aiding in
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indicate socioeconomic transition of Bangladesh.39–45,51 The
key ﬁnding of HIES-201044 is that the standard of living of the
population in general has improved very signiﬁcantly in recent
years. This is reﬂected in reduced incidence of poverty with
stability in the distribution of income and expenditure;
increased nutrition from a more diversiﬁed food consumption
basket; and higher level of living in terms of non-food indicators.
Bangladesh has made considerable progress in achieving
the Millennium Development Goals (MDGs). According to the
latest report, the country is on track or has already achieved 5
of the 8 MDG goals77; remarkable progress has been made in
the areas of poverty alleviation, primary school enrolment,
gender parity in primary and secondary level education,
lowering the infant and under-5 mortality rate and maternal
mortality ratio, improving immunization coverage, and
reducing the incidence of communicable diseases. Poverty
declined 1.8% annually between 2000 and 2005, and 1.7%
annually between 2005 and 2010, number of poor people
decreased from nearly 63 million in 2000, 55 million in 2005,
and to 47 million in 2010. Despite a growing population, the
proportion of poor people declined by 26% in 10 years.78 In
terms of MDGs, 2 years ahead of time, in 2013, it has been
possible to reduce poverty to 26.2%, whereas the goal was to
bring poverty down to 29% by the year 2015.77 According to the
HIES-2010,55 per capita per day intake of food items has
increased by 5.4% to 1000.0 g in 2010 from 947.8 g in 2005 at the
national level. The overall calorie intake per capita per day
increased by 3.56% to 2318.3 kcal in 2010 from 2238.5 kcal in
2005; protein intake has increased to 66.26 g per capita per day
in 2010 from 62.52 g per capita per day in 2005. The average size
of household has continued to decrease. It has declined from
4.84 in 2005 to 4.5 in 2010.55 Access to education has increased.
Literacy rate of population aged 7 years and over stands at
57.91% at national level, compared with 51.9% in 2005.44 The
proportion of people beneﬁting from at least one public safety
net program has increased; in 2010, 24.57% of the households
reported to have received beneﬁt during the last 12 months
from at least one type of program, in contrast, only 13.06%
households reported to have received beneﬁt from Social
Safety Net Programs (SSNP) in 2005.44
Besides decline in poverty and improvement in lifestyle,
Bangladesh has achieved considerable success in health sector
in recent decades. This success might be attributed to a
pluralistic health system with many stakeholders, including
government and non-governmental organizations, who pur-
sue women-focused, equity-oriented, nationally targeted
programs, such as those in family planning, immunization,
oral rehydration therapy, maternal and child health, tubercu-
losis, vitamin A supplementation, and others.36 Health care
facilities have increased in both public and private sectors; day
by day, specialist services are becoming available even in rural
and remote areas including Upazila level (subunit of a district,
analogous to that of a county or borough of Western countries).
Other factors playing important role in controlling acute RF
include easy availability and widespread use of antibiotic
(though may not be appropriate/supportable) by the registered
and unregistered medical practitioners, which might lead to
treatment of streptococcal sore throat, among other causes,
preventing RF.Echocardiography is being more widely used for diagnosis
of cardiac diseases. At present, majority of the machines used
are probably not dedicated echo machines, rather they are
ultrasonography devices able to perform 2D and M-mode
studies, and the expertise of the echocardiographers may not
always be up to the mark. However, despite these pitfalls, they
are playing role as least as a screening tool for diagnosis of
established cases of chronic RHD. Though in limited scale,
transesophageal echocardiography (TEE) is available for better
evaluation as well.79
Side by side of better diagnosis, treatment facilities have
also increased. In the recent decades, treatment modalities of
chronic RHD especially mitral valvular disease have gone
through evolution, which has been reﬂected in Bangladesh as
well. Classically, severe cases of MS with suitable valve
morphology were managed by surgery, i.e. closed mitral
commissurotomy (CMC). For the ﬁrst time, a few cases of CMC
were done in Institute of Post-Graduate Medicine & Research
(IPGMR) in 1973 by Prof. Ali Ashraf, and then in National
Institute of Diseases of Chest & Hospital (NIDCH) in 1979 by
Prof. SR Khan (Ahmed NU, Professor of Cardiac Surgery,
personal communication, 25 Dec 2013). CMC started in NICVD
in 1980, and since then, a good number of cases were done at
low cost with good results.79–81 In a study involving 1500
CMCs, done in NICVD between June 1980 and June 1990, 30%
patients were of juvenile age group, i.e. up to 20 years, and
the results were encouraging with 30-day mortality 2%,
restenosis 18%, and signiﬁcant mitral regurgitation 4% in
long-term follow up.80 Subsequently, with the introduction
of percutaneous transvenous mitral commissurotomy
(PTMC) in 1996, MS patients were managed by this modality
predominantly, because PTMC is less invasive, leaves no scar
in the chest wall, requires more or less similar cost, and the
outcomes are good.82,83 However, open mitral commissur-
otomy (OMC) is being used for suitable, complicated cases,
like before. On the other hand, for mitral valve replacement,
some bioprostheses were used initially, which were later
almost replaced by metalloprostheses. Initial ball-and-case
metallic valves are out of use nowadays, and majority of the
prostheses used today are bileaﬂet valves. Despite presence
of indications, anticoagulants are not given in many high-
risk patients with chronic RHD, because of fear of bleeding
and lack of adequate monitoring facility. Single or dual
antiplatelets are used more commonly, sometimes, without
sticking to the guidelines. However, the practice is gradually
changing.
Like many other countries, with the control of communi-
cable diseases, non-communicable diseases including CVDs,
are getting more attention even in Bangladesh. Among the
CVDs, coronary artery disease is being given the topmost
priority, and side by side, RF and RHD are receiving less
attention. In fact, at present, no speciﬁc program for control of
RF and RHDs exist in the country. In the past, NCCRF&HD
played important role in overall management of RF and
chronic RHD. Subsequently, with the control of acute cases of
RF, its role decreased, which is at present mainly limited to
health education, and epidemiological research. The institu-
tion lacks facilities for interventional and surgical manage-
ment of RHD. In this way, despite promise, it seems to be
under-utilized.
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In recent years, there is a surge of interest in RF and RHD in
regions of the world where these diseases mostly occur.84
Global organizations, including the WHO and the WHF, are
also paying increasing interest, and showing greater efforts in
controlling RF and RHD. The WHF has made a major
commitment to leading the charge on RHD control, taking
the mantle from the WHO.84 The WHF's mission is to
'minimize the burden of RHD and eliminate RF', for which it
has set the goal of achieving a 25% reduction in premature
deaths from RF and RHD among individuals aged <25 years by
2025.1 The targets of the WHF are: to ensure that 90% of
countries with endemic RHD have integrated and comprehen-
sive control programs by 2025; to ensure the availability of
high-quality benzathine penicillin G for 90% of patients with
RHD in 90% of countries with a high burden of this disease
within 10 years; to foster at least one prominent public ﬁgure
as an 'RHD champion' in every country where RHD is endemic,
to establish at least one hub of training, research, and
advocacy for RF and RHD in each WHO-deﬁned geographic
region by 2025; and to test a GABHS vaccine in phase III clinical
trials in RHD-endemic countries within 10 years.1 Bangladesh
can align herself with the international communities, formu-
late appropriate policies, and act accordingly to combat RF and
RHD. Under the auspices of WHO and WHF, the country can
utilize her extensive network of non-Government Organiza-
tions (NGOs) like the Bangladesh Rural Advancement Com-
mittee (BRAC) and Association for Social Advancement (ASA),
who are already boosting the Government's effort to control
communicable diseases like TB. Data related to different
aspects of RF and RHD in Bangladesh are inadequate. Large,
preferably nationwide epidemiological and clinical studies
should be carried out to gain reliable information on this
important public health issue. RF and RHD can be declared a
notiﬁable disease, and a national registry can be formulated to
keep the record of and track the RF and RHD cases. Renovation
of NCCRF&HD may be done to boost up research in RF and
chronic RHD and render point-of-care services involving
medical, interventional, as well as, surgical modalities of
treatment. It can be a reference center for RF and RHD in South
Asia. The existing Doctors' Manual on Rheumatic Fever85 is more
than a decade old, so it should be updated. Appropriate
guidelines may be formulated in relation to RF and RHD to
bring about uniformity and rationality in existing practice.
Guidelines formulated by the WHO, the Indian Academy of
Pediatrics, the National Heart Foundation of New Zealand and
the Cardiac Society of Australia and New Zealand, and the
WHF can be considered.34,86–90 Introduction of portable echo
machine may lead to more versatile use of this useful tool for
the diagnosis and follow up of RF and RHD, and gathering
reliable data for research. Side by side, proper and adequate
training in echocardiography should be ensured, because, at
present, this sector appears to be relatively neglected in
Bangladesh, and the country seriously lacks competent
echocardiographers. The PTMC hardwires and prosthetic
valves are quite expensive; local manufacture and probable
reuse can cut down the cost to a signiﬁcant extent. More
research is needed on bioprosthesis, so that hassles ofanticoagulation can be avoided. Treatment of RF and conse-
quent RHD is clumsy, expensive, and is often only palliative;
timely prevention can only reduce this great taxation. Further
economic upliftment, better housing and lifestyle may be
helpful in this regard. CVD prevention should be integrated
with primary health care. Cardiovascular health promotion
should be part of the national media strategy and the health
education curriculum. Intensive research, may be in collabo-
ration with international organizations, should be undertaken
to explore the different aspects of RF and RHD in Bangladesh.
10. Conclusion
Despite much advancement, RF and RHD are prevalent in
Bangladesh. At the advent of the new millennium, we know
little about our real situation. The existing disease burden may
actually represent the tip of the iceberg. We have no more time
to lapse. Large-scale, preferably, nation-wide survey and
clinical research should be conducted to determine the
different aspects of RF and RHD in Bangladesh. The informa-
tion available thereby, would help to formulate national policy
to combat this public health problem more efﬁciently in future.
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